Epharmacy Startups Claim Delay In Government’s Official Guidelines Hurts Ease Of Doing Business

Epharmacy Startups Claim Delay In Government’s Official Guidelines Hurts Ease Of Doing Business

SUMMARY

1mg, Pharmeasy, Medlife and Netmeds banded together to address issues around epharmacy policy

The government’s guidelines have not been finalised in over a year

Epharmacies say this policy standstill affects their business and growth plans

In August 2018, the government had released guidelines for epharmacy companies under the Drugs and Cosmetics Act. After multiple feedback rounds and more than a year later, there has been no update. And leading epharmacy players in India such as 1mg, Pharmeasy, Medlife and Netmeds have banded together to highlight their concerns on the delay of these rules.

Addressing reporters on Tuesday (December 3), 1mg founder and CEO Prashant Tandon said that they have been discussing with regulators and ministries for over four years and have participated in multiple stakeholder discussions. He emphasised that the long policy holdup is causing issues in ease of doing business for epharmacies.

On similar lines, Pharmeasy cofounder and CEO Dharmil Sheth added that he hopes the government acknowledges the benefits of digital penetration in the category and empowers every stakeholder with a robust framework and governance module. He called for immediate clarity on the rules that govern online medicine selling.

Tandon also referred to reports of epharmacies being illegal as bogus and emphasised that their businesses are legally sound. It is to be noted that the epharmacy startups found themselves in the government’s crosshairs last year and since then have been struggling to find the right regulatory approvals to expand their business.

Yogesh Shukla, director, MedLife also spoke about similar issues and said that the government should take the concerns seriously.

Unclear Rules For Epharmacy Startups

In October 2018, the Madras High Court announced a ban on the online sale of medicines. The court directed the central government to make its stand clear on the rules regarding epharmacies and the sale of medicines online in their judgements.

The group of epharmacies said that they want regulations to be finalised so that the business can function without hiccups. 1mg’s Tandon said that the legal processes are taking too long and hence, cause hurdles in growth.

“We think government should have timebound mechanism to handle issues,” Tandon said.

Pharmeasy’s Sheth said the government should now act to improve ease of doing business rather than talking about it. He emphasised that it is very critical to operating in healthtech industry, and it is becoming difficult to run and manage operations every day.

“The government should look at what benefits people than looking at what benefits set of vested interest groups,” Sheth added.

You have reached your limit of free stories
Become An Inc42 Plus Member

Become a Startup Insider in 2024 with Inc42 Plus. Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in India’s startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
Unlock 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
Unlock 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

Epharmacy Startups Claim Delay In Government’s Official Guidelines Hurts Ease Of Doing Business-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

Epharmacy Startups Claim Delay In Government’s Official Guidelines Hurts Ease Of Doing Business-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

Epharmacy Startups Claim Delay In Government’s Official Guidelines Hurts Ease Of Doing Business-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

Epharmacy Startups Claim Delay In Government’s Official Guidelines Hurts Ease Of Doing Business-Inc42 Media
Epharmacy Startups Claim Delay In Government’s Official Guidelines Hurts Ease Of Doing Business-Inc42 Media
You’re in Good company